|
1
|
Grier HE: The Ewing family of tumors.
Ewing’s sarcoma and primitive neuroectodermal tumors. Pediatr Clin
North Am. 44:991–1004. 1997.
|
|
2
|
McManus AP, Gusterson BA, Pinkerton CR and
Shipley JM: The molecular pathology of small round-cell tumours –
relevance to diagnosis, prognosis, and classification. J Pathol.
178:116–121. 1996.
|
|
3
|
Stiller CA, Bielack SS, Jundt G and
Steliarova-Foucher E: Bone tumours in European children and
adolescents, 1978–1997 report from the Automated Childhood Cancer
Information System project. Eur J Cancer. 42:2124–2135. 2006.
|
|
4
|
Leavey PJ, Mascarenhas L, Marina N, Chen
Z, Krailo M, Miser J, Brown K, Tarbell N, Bernstein ML, Granowetter
L, Gebhardt M and Grier HE; Children’s Oncology Group. Prognostic
factors for patients with Ewing sarcoma (EWS) at first recurrence
following multi-modality therapy: a report from the Children’s
Oncology Group. Pediatr Blood Cancer. 51:334–338. 2008.PubMed/NCBI
|
|
5
|
Athale U, Cox S, Siciliano S and Chan AK:
Thromboembolism in children with sarcoma. Pediatr Blood Cancer.
49:171–176. 2007. View Article : Google Scholar
|
|
6
|
Grier HE, Krailo MD, Tarbell NJ, Link MP,
Fryer CJ, Pritchard DJ, Gebhardt MC, Dickman PS, Perlman EJ, Meyers
PA, Donaldson SS, Moore S, Rausen AR, Vietti TJ and Miser JS:
Addition of ifosfamide and etoposide to standard chemotherapy for
Ewing’s sarcoma and primitive neuroectodermal tumor of bone. N Engl
J Med. 348:694–701. 2003.
|
|
7
|
Nesbit ME: Ewing’s sarcoma. CA Cancer J
Clin. 26:174–180. 1976.
|
|
8
|
Indelicato DJ, Keole SR, Shahlaee AH, Shi
W, Morris CG, Gibbs CP Jr, Scarborough MT and Marcus RB Jr: Impact
of local management on long-term outcomes in Ewing tumors of the
pelvis and sacral bones: the University of Florida experience. Int
J Radiat Oncol Biol Phys. 72:41–48. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bacci G, Balladelli A, Forni C, Ferrari S,
Longhi A, Benassi MS, Briccoli A, Serra M and Picci P: Adjuvant and
neoadjuvant chemotherapy for Ewing sarcoma family tumors in
patients aged between 40 and 60: report of 35 cases and comparison
of results with 586 younger patients treated with the same
protocols in the same years. Cancer. 109:780–786. 2007.
|
|
10
|
Sciubba DM, Petteys RJ, Garces-Ambrossi
GL, Noggle JC, McGirt MJ, Wolinsky JP, Witham TF and Gokaslan ZL:
Diagnosis and management of sacral tumors. J Neurosurg Spine.
10:244–256. 2009. View Article : Google Scholar
|
|
11
|
Paulussen M, Bielack S, Jurgens H and
Casali PG; ESMO Guidelines Working Group. Ewing’s sarcoma of the
bone: ESMO clinical recommendations for diagnosis, treatment and
follow-up. Ann Oncol. 20(Suppl 4): 140–142. 2009.
|
|
12
|
Skubitz KM and D’Adamo DR: Sarcoma. Mayo
Clin Proc. 82:1409–1432. 2007. View Article : Google Scholar
|
|
13
|
Bacci G, Ferrari S, Longhi A, Donati D, De
Paolis M, Forni C, Versari M, Setola E, Briccoli A and Barbieri E:
Therapy and survival after recurrence of Ewing’s tumors: the
Rizzoli experience in 195 patients treated with adjuvant and
neoadjuvant chemotherapy from 1979 to 1997. Ann Oncol.
14:1654–1659. 2003.
|
|
14
|
Hanna SA, David LA, Gikas PD, Tindall AJ,
Cannon SR and Briggs TW: Very late local recurrence of Ewing’s
sarcoma – can you ever say ‘cured’? A report of two cases and
literature review. Ann R Coll Surg Engl. 90:W12–W15. 2008.
|
|
15
|
Yock TI, Krailo M, Fryer CJ, Donaldson SS,
Miser JS, Chen Z, Bernstein M, Laurie F, Gebhardt MZ, Grier HE and
Tarbell NJ; Children’s Oncology Group. Local control in pelvic
Ewing sarcoma: analysis from INT-0091 – a report from the
Children’s Oncology Group. J Clin Oncol. 24:3838–3843.
2006.PubMed/NCBI
|
